Multidrug-resistant tuberculosis (MDR-TB)

<img width="150" height="150" src="https://lunginstitute.co.za/wp-content/uploads/2023/09/satsgsk-150x150.jpg" class="attachment-be_thumbnail size-be_thumbnail wp-post-image" alt="" decoding="async" />

EducAir Online Educational Series

28th September 2023

<img width="150" height="150" src="https://lunginstitute.co.za/wp-content/uploads/2023/11/TB-Surpasses-Covid-19-150x150.jpg" class="attachment-be_thumbnail size-be_thumbnail wp-post-image" alt="" decoding="async" />

Tuberculosis Surpasses COVID-19 as Most Deadly Infectious Disease

17th November 2023

<img width="150" height="150" src="https://lunginstitute.co.za/wp-content/uploads/2023/09/satsgsk-150x150.jpg" class="attachment-be_thumbnail size-be_thumbnail wp-post-image" alt="" decoding="async" />

EducAir Online Educational Series

28th September 2023

<img width="150" height="150" src="https://lunginstitute.co.za/wp-content/uploads/2023/11/TB-Surpasses-Covid-19-150x150.jpg" class="attachment-be_thumbnail size-be_thumbnail wp-post-image" alt="" decoding="async" />

Tuberculosis Surpasses COVID-19 as Most Deadly Infectious Disease

17th November 2023

Multidrug-resistant tuberculosis (MDR-TB)

Press Releases 2023

Multidrug-resistant tuberculosis (MDR-TB): Clinical trial starts in South Africa

Click on the image to read the full article.